Federal health officials have proposed loosening a ban on mitragynine pseudoindoxyl, or MGPI, a potent opioid compound found in some kratom products, to allow the substance at certain levels, The New York Times reported Oct. 28. HHS Secretary Robert F. Kennedy Jr. announced the policy shift Oct. 9. The Drug Enforcement Administration said July 1 that it planned to ban MGPI and two other compounds, and the Justice Department announced emergency temporary scheduling of the compounds Aug. 25. The revised policy continues to prohibit highly concentrated MGPI products but would… Originally published in Becker’s Hospital Review. Read More
White House walks back proposed kratom opioid ban despite safety concerns
Integrated Psychiatric Consultants
Office Hours:Mon-Fri, 9 a.m. - 5 p.m. CT